Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pressure Biosciences (PBIO)

Pressure Biosciences (PBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 4,690
  • Shares Outstanding, K 2,357
  • Annual Sales, $ 2,460 K
  • Annual Income, $ -9,700 K
  • 60-Month Beta 1.25
  • Price/Sales 2.11
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -8.81
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/13/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6300 +19.63%
on 11/07/19
2.6500 -26.42%
on 10/15/19
-0.7000 (-26.42%)
since 10/11/19
3-Month
1.2500 +56.00%
on 08/16/19
3.5000 -44.29%
on 09/10/19
-0.3500 (-15.22%)
since 08/12/19
52-Week
1.2500 +56.00%
on 08/16/19
4.0300 -51.61%
on 04/15/19
-1.2500 (-39.06%)
since 11/12/18

Most Recent Stories

More News
Biotechs Strive to Combat Rising Cancer Mortality Rates

FinancialBuzz.com News Commentary

ABT : 84.34 (+0.69%)
ABBV : 86.44 (+0.91%)
BMY : 58.39 (+0.41%)
CVM : 6.88 (-0.29%)
PBIO : 1.9500 (-2.01%)
Biotechs Strive to Combat Rising Cancer Mortality Rates

Cancer is a disease that involves the abnormal growth of cells which results in the formation of a tumor. The abnormal cells have a tendency to spread to other local tissues and may also spread to different...

PBIO : 1.9500 (-2.01%)
CVM : 6.88 (-0.29%)
ABBV : 86.44 (+0.91%)
BMY : 58.39 (+0.41%)
ABT : 84.34 (+0.69%)
Zacks Small Cap Research Initiates Coverage on Pressure BioSciences, Inc.

via OTC PR WIRE - Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology...

PBIO : 1.9500 (-2.01%)
Pressure BioSciences' Proprietary PCT Platform Fills Pivotal Role for Tumor Analyses in Novel Workflow Presented at Leading Global Gynecologic Cancer Meeting

via OTC PR WIRE - Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology...

PBIO : 1.9500 (-2.01%)
Pressure BioSciences Provides Corporate Update, Focus on CBD Market and Growth Drivers for 2019-2020 in New SNNLive Video Interview on StockNewsNow.com

LOS ANGELES, CA / ACCESSWIRE / September 27, 2019 / , The Official MicroCap News Source™, today published an SNNLive Video Interview with Richard T. Schumacher, President and CEO of Pressure BioSciences,...

PBIO : 1.9500 (-2.01%)
Pressure BioSciences' PCT Platform Featured in Multiple Presentations at Major International Science Conference

EQNX::TICKER_START (OTCQB:PBIO), EQNX::TICKER_END

PBIO : 1.9500 (-2.01%)
Biotech Companies Endeavor to Address Global Health Issues

FinancialBuzz.com News Commentary

AZN : 47.08 (+0.43%)
GSK : 44.52 (+0.59%)
MRK : 84.12 (+1.01%)
PFE : 36.97 (+0.11%)
PBIO : 1.9500 (-2.01%)
Biotech Companies Endeavor to Address Global Health Issues

The global burden of diseases continues to grow each year, despite ongoing medical advancements. The Institute for Health Metrics and Evaluation (IHME) highlighted in a report that between 1950 and 2017,...

GSK : 44.52 (+0.59%)
PBIO : 1.9500 (-2.01%)
MRK : 84.12 (+1.01%)
PFE : 36.97 (+0.11%)
AZN : 47.08 (+0.43%)
Pressure BioSciences, Inc. Discusses Major Advancements Its PCT, BaroFold, and BaroShear K45 Platforms

Phoenix, Arizona--(Newsfile Corp. - September 18, 2019) - The Stock Day Podcast recently welcomed Mr. Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO) ("the Company"),...

PBIO : 1.9500 (-2.01%)
Pressure BioSciences Prepares for Growth, Adding Daniel J. Shea as Chief Financial Officer

EQNX::TICKER_START (OTCQB:PBIO), EQNX::TICKER_END

PBIO : 1.9500 (-2.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade PBIO with:

Key Turning Points

2nd Resistance Point 2.0167
1st Resistance Point 1.9833
Last Price 1.9500
1st Support Level 1.9333
2nd Support Level 1.9167

See More

52-Week High 4.0300
Fibonacci 61.8% 2.9680
Fibonacci 50% 2.6400
Fibonacci 38.2% 2.3120
Last Price 1.9500
52-Week Low 1.2500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar